Valuation: DHG Pharmaceutical

Market Cap 10,852B 422M 384M 354M 322M 605M 39.09B 635M 4.31B 1.71B 21.35B 1.58B 1.55B 67B P/E 2026 *
11.7x
P/E 2027 * 11x
Enterprise Value 8,989B 350M 318M 293M 267M 501M 32.38B 526M 3.57B 1.42B 17.68B 1.31B 1.28B 55.5B EV / Sales 2026 *
1.65x
EV / Sales 2027 * 1.58x
Free-Float
48.78%
Yield 2026 *
8.43%
Yield 2027 * 8.67%
10-20 DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 CI
08-20 DHG Pharma Announces Final Dividend for 2025, Payable on 30 Sep. 2026 CI
07-20 DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
07-14 Large Enterprise Tax Sub-Department Imposes Administrative Penalty on DHG Pharmaceutical Joint Stock Company CI
05-24 DHG Pharmaceutical Joint Stock Company Receives the Confirmation Certificate of Registration Changes CI
04-29 DHG Pharmaceutical Joint Stock Company Announces Adjustment of Position of Osamu Fujimori as Deputy General Director in Charge of Finance and Supply Chain, Effective May 1, 2026 CI
04-22 DHG Pharmaceutical Joint Stock Company Provides Earnings Guidance for 2026 CI
04-22 DHG Pharmaceutical Joint Stock Company Announces Board Changes, Effective April 21, 2026 CI
04-22 DHG Pharmaceutical Joint Stock Company Approves Dividend for the Fiscal Year Ended December 31, 2025, Payable on 28 May 2026 and in September 2026 CI
04-22 DHG Pharmaceutical Joint Stock Company Provides Dividend Guidance for the Fiscal Year 2026 CI
04-20 DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-26 DHG Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2026 CI
01-20 DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
1 day-1.19%
1 week-2.47%
Current month-4.49%
1 month-7.57%
3 months-11.04%
6 months-12.08%
Current year-18.87%
1 week 83,000
Extreme 83000.00000000
86,300
1 month 82,300
Extreme 82300
88,900
Current year 82,300
Extreme 82300
109,000
1 year 82,300
Extreme 82300
109,000
3 years 82,300
Extreme 82300
125,900
5 years 78,000
Extreme 78000
142,500
10 years 61,000
Extreme 60999.999999
142,500
Manager TitleAgeSince
Chief Executive Officer 59 -
Director of Finance/CFO - -
Chief Executive Officer 52 2017-08-31
Director TitleAgeSince
Director/Board Member 52 2000-02-29
Director/Board Member 70 2016-08-14
Chairman - 2019-06-10
Date Insider Type Main position Quantity % Market Cap. Importance
5/26/22 Buy

Chief Financial Officer

18,700 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
-1.19%-2.47%-19.10%-19.88% 427M
-0.30%-6.68%+29.12%+125.42% 1,204B
+1.25%-5.35%+33.19%+80.42% 643B
+0.94%-2.99%+24.73%+106.93% 501B
-0.60%-1.95%+27.26%+67.32% 378B
+0.69%-9.50%+40.80%+30.23% 327B
+0.41%-4.70%+27.23%+51.59% 285B
+0.81%-4.08%-1.74%+32.71% 270B
-0.15%-6.45%+29.63%+64.18% 237B
-0.06%-0.98%+33.15%+118.99% 207B
Average +0.21%-4.61%+22.43%+65.79% 405B
Weighted average by Cap. +0.39%-5.21%+28.03%+87.58%

Financials

2026 *2027 *
Net sales 5,435B 211M 193M 177M 161M 303M 19.58B 318M 2.16B 858M 10.69B 793M 776M 33.56B 5,691B 221M 202M 186M 169M 317M 20.5B 333M 2.26B 899M 11.19B 830M 813M 35.13B
Net income 928B 36.11M 32.89M 30.31M 27.57M 51.72M 3.34B 54.35M 369M 147M 1.83B 135M 133M 5.73B 983B 38.25M 34.84M 32.1M 29.2M 54.78M 3.54B 57.57M 391M 155M 1.93B 144M 140M 6.07B
Net Debt -1,862B -72.44M -65.98M -60.8M -55.3M -104M -6.71B -109M -740M -294M -3.66B -272M -266M -11.5B -1,858B -72.26M -65.81M -60.64M -55.16M -103M -6.69B -109M -738M -293M -3.65B -271M -265M -11.47B
Projected Income Statement - Annual - DHG Pharmaceutical
Logo DHG Pharmaceutical
DHG Pharmaceutical Joint Stock Company is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures and markets pharmaceutical products, vitamins, supplements and cosmetics. Via its subsidiaries, the Company is also involved in packaging printing, herb cultivation, medicinal supplies trading, as well as domestic travel tour and medical clinic operation.
Employees
2,812
Date Price Change Volume
26-11-20 ₫83,000.00 -1.19% 5,708
26-11-19 ₫84,000.00 -0.36% 3,004
26-11-18 ₫84,300.00 -0.82% 3,165
26-11-17 ₫85,000.00 -0.58% 5,842
26-11-16 ₫85,500.00 +0.47% 9,154
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - DHG Pharmaceutical
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
83,000.00VND
Average target price
97,600.00VND
Spread / Average Target
+17.59%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - DHG Pharmaceutical